Posterior reversible encephalopathy syndrome and cerebral vasculopathy associated with influenza a infection: Report of a case and review of the literature

Journal of Computer Assisted Tomography

Volumn 33, Issue 6, 2009, Pages 917-922

  Bartynski, Walter S ^a   Upadhyaya, Ameet R ^a   Boardman, John F ^a  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

Angiography; Influenza; Magnetic resonance imaging; Posterior reversible encephalopathy syndrome; PRES; Stroke; Vasculopathy

Indexed keywords

NEURODEGENERATIVE DISEASES;

CEREBRAL ANGIOGRAMS; CEREBRAL EDEMA; INFLUENZA; INFLUENZA A; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; REYE'S SYNDROME; STROKE; VASCULOPATHY;

MAGNETIC RESONANCE IMAGING;

ACICLOVIR; AMPICILLIN; CEFTRIAXONE; OSELTAMIVIR; VANCOMYCIN;

AGED; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MENINGITIS; BLOOD PRESSURE; BRAIN; BRAIN ANGIOGRAPHY; CASE REPORT; CEREBROVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; ERYTHROCYTE; FEMALE; HERPES SIMPLEX; HOSPITAL ADMISSION; HUMAN; INFLUENZA; INFLUENZA VIRUS A; INTUBATION; LEUKOCYTE COUNT; LUMBAR PUNCTURE; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; VIRUS INFECTION; HYPERTENSION ENCEPHALOPATHY; ISOLATION AND PURIFICATION; SYNDROME;

AGED; CEREBRAL ANGIOGRAPHY; CEREBROVASCULAR DISORDERS; FEMALE; HUMANS; HYPERTENSIVE ENCEPHALOPATHY; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MAGNETIC RESONANCE IMAGING; SYNDROME; TOMOGRAPHY, X-RAY COMPUTED;

EID: 68549130199     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/RCT.0b013e3181993a43     Document Type: Article

References (74)

1. Okabe N, Yamashita K, Taniguchi K, et al. Influenza surveillance system of Japan and acute encephalitis and encephalopathy in the influenza season. Pediatr Int. 2000;42:187-191.
2. Morishima T, Togashi T, Yokota S, et al. Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clin Infect Dis. 2002;35:512-517.
3. Wang YH, Huang YC, Chang LY, et al. Clinical characteristics of children with influenza A virus infection requiring hospitalization. J Microbiol Immunol Infect. 2003;36:111-116.
4. Elkind MS. Why now? Moving from stroke risk factors to stroke triggers. Curr Opin Neurol. 2007;20:51-57.
5. Grau AJ, Fischer B, Barth C, et al. Influenza vaccination is associated with a reduced risk of stroke. Stroke. 2005;36:1501-1506.
6. Collins SD. Excess mortality from causes other than influenza and pneumonia during influenza epidemics. Public Health Rep. 1932;47: 2159-2179.
7. Housworth J, Langmuir AD. Excess mortality from epidemic influenza, 1957-1966. Am J Epidemiol. 1974;100:40-48.
8. Alling DW, Blackwelder WC, Stuart-Harris CH. A study of excess mortality during influenza epidemics in the United States, 1968-1976. Am J Epidemiol. 1981;113:30-43.
9. Kizilkilic O, Karaca S. Influenza-associated encephalitis-encephalopathy with a reversible lesion in the splenium of the corpus callosum: case report and literature review. AJNR Am J Neuroradiol. 2004;25: 1863-1864.
10. Takanashi J, Barkovich AJ, Yamaguchi K, et al. Influenza-associated encephalitis/encephalopathy with a reversible lesion in the splenium of the corpus callosum: a case report and literature review. AJNR Am J Neuroradiol. 2004;25:798-802.
11. Kirton A, Busche K, Ross C, et al. Acute necrotizing encephalopathy in Caucasian children: two cases and review of the literature. J Child Neurol. 2005;20:527-532.
12. Surtees R, DeSousa C. Influenza virus associated encephalopathy. Arch Dis Child. 2006;91:455-456.
13. Studahl M. Influenza virus and CNS manifestations. J Clin Virol. 2003;28:225-232.
14. Fujimoto S, Kobayashi M, Uemura O, et al. PCR on cerebrospinal fluid to show influenza-associated acute encephalopathy or encephalitis. Lancet. 1998;352:873-875.
15. Togashi T, Matsuzono Y, Narita M. Epidemiology of influenza-associated encephalitis-encephalopathy in Hokkaido, the northernmost island of Japan. Pediatr Int. 2000;42:192-196.
16. Visseren FL, Verkerk MS, Bouter KP, et al. Interleukin-6 production by endothelial cells after infection with influenza virus and cytomegalovirus. J Lab Clin Med. 1999;134:623-630.
17. Visseren FL, Bouwman JJ, Bouter KP, et al. Procoagulant activity of endothelial cells after infection with respiratory viruses. Thromb Haemost. 2000;84:319-324.
18. Davis LE, Kornfeld M, Daniels RS, et al. Experimental influenza causes a non-permissive viral infection of brain, liver and muscle. J Neurovirol. 2000;6:529-536.
19. Klenk HD. Infection of the endothelium by influenza viruses. Thromb Haemost. 2005;94:262-265.
20. Flewett TH, Hoult JG. Influenzal encephalopathy and postinfluenzal encephalitis. Lancet. 1958;2:11-15.
21. Frankova V, Jirasek A, Tumova B. Type A influenza: postmortem virus isolations from different organs in human lethal cases. Arch Virol. 1977;53:265-268.
22. Horner FA. Neurologic disorders after Asian influenza. N Engl J Med. 1958;258:983-985.
23. Kapila CC, Kaul S, Kapur SC, et al. Neurological and hepatic disorders associated with influenza. Br Med J. 1958;2:1311-1314.
24. Oseasohn R, Adelson L, Kaji M. Clinicopathologic study of thirty-three fatal cases of Asian influenza. N Engl J Med. 1959;260:509-518.
25. Nakai Y, Itoh M, Mizuguchi M, et al. Apoptosis and microglial activation in influenza encephalopathy. Acta Neuropathol. 2003;105:233-239.
26. Yagishita A, Nakano I, Ushioda T, et al. Acute encephalopathy with bilateral thalamotegmental involvement in infants and children: imaging and pathology findings. AJNR Am J Neuroradiol. 1995;16:439-447.
27. Takahashi M, Yamada T, Nakashita Y, et al. Influenza virus-induced encephalopathy: clinicopathologic study of an autopsied case. Pediatr Int. 2000;42:204-214.
28. Matsubara K, Kodera M, Nigami H, et al. Reversible splenial lesion in influenza virus encephalopathy. Pediatr Neurol. 2007; 37:431-434.
29. Hagemann G, Mentzel HJ, Weisser H, et al. Multiple reversible MR signal changes caused by Epstein-Barr virus encephalitis. AJNR Am J Neuroradiol. 2006;27:1447-1449.
30. Takanashi J, Barkovich AJ, Shiihara T, et al. Widening spectrum of a reversible splenial lesion with transiently reduced diffusion. AJNR Am J Neuroradiol. 2006;27:836-838.
31. Kimura E, Okamoto S, Uchida Y, et al. A reversible lesion of the corpus callosum splenium with adult influenza-associated encephalitis/encephalopathy: a case report. J Med Case Reports. 2008;2:220.
32. Belay ED, Bresee JS, Holman RC, et al. Reye's syndrome in the United States from 1981 through 1997. N Engl J Med. 1999;340: 1377-1382.
33. Russell EJ, Zimmerman RD, Leeds NE, et al. Reye syndrome: computed tomographic documentation of disordered intracerebral structure. J Comput Assist Tomogr. 1979;3:217-220.
34. Johnsen SD, Bird CR. The thalamus and midbrain in Reye syndrome. Pediatr Neurol. 2006;34:405-407.
35. Ozdoba C, Pfenninger J, Schroth G. Initial and follow-up MRI in a case of early diagnosed Reye's syndrome. Neuroradiology. 1997;39: 495-498.
36. Lavallee P, Perchaud V, Gautier-Bertrand M, et al. Association between influenza vaccination and reduced risk of brain infarction. Stroke. 2002;33:513-518.
37. Meyers DG. Myocardial infarction, stroke, and sudden cardiac death may be prevented by influenza vaccination. Curr Atheroscler Rep. 2003;5:146-149.
38. Meyers DG. Could influenza vaccination prevent myocardial infarction, stroke and sudden cardiac death? Am J Cardiovasc Drugs. 2003;3: 241-244.
39. Nichol KL, Nordin J, Mullooly J, et al. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med. 2003;348:1322-1332.
40. Smeeth L, Thomas SL, Hall AJ, et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004;351: 2611-2618.
41. Treanor JJ. Influenza virus. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Philadelphia, PA: Elsevier; 2005:2060-2085.
42. Bova IY, Bornstein NM, Korczyn AD. Acute infection as a risk factor for ischemic stroke. Stroke. 1996;27:2204-2206.
43. Diaz J, Sempere AP. Cerebral ischemia: new risk factors. Cerebrovasc Dis. 2004;17:43-50.
44. Grau AJ, Buggle F, Becher H, et al. Recent bacterial and viral infection is a risk factor for cerebrovascular ischemia: clinical and biochemical studies. Neurology. 1998;50:196-203.
45. Grau AJ, Buggle F, Heindl S, et al. Recent infection as a risk factor for cerebrovascular ischemia. Stroke. 1995;26:373-379.
46. Grau AJ, Buggle F, Ziegler C, et al. Association between acute cerebrovascular ischemia and chronic and recurrent infection. Stroke. 1997;28:1724-1729.
47. Syrjanen J, Valtonen VV, Iivanainen M, et al. Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients. Br Med J (Clin Res Ed). 1988;296: 1156-1160.
48. Bell ML, Buchhalter JR. Influenza AYassociated stroke in a 4-year-old male. Pediatr Neurol. 2004;31:56-58.
49. Naghavi M, Wyde P, Litovsky S, et al. Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein EYdeficient mice. Circulation. 2003;107: 762-768.
50. Marchesi S, Lupattelli G, Lombardini R, et al. Acute inflammatory state during influenza infection and endothelial function. Atherosclerosis. 2005;178:345-350.
51. Keller TT, van der Meer JJ, Teeling P, et al. Selective expansion of influenza AvirusYspecific T cells in symptomatic human carotid artery atherosclerotic plaques. Stroke. 2008;39:174-179.
52. Macko RF, Ameriso SF, Gruber A, et al. Impairments of the protein C system and fibrinolysis in infection-associated stroke. Stroke. 1996;27:2005-2011.
53. Muir KW, Weir CJ, Alwan W, et al. C-reactive protein and outcome after ischemic stroke. Stroke. 1999;30:981-985.
54. Grau AJ, Boddy AW, Dukovic DA, et al. Leukocyte count as an independent predictor of recurrent ischemic events. Stroke. 2004;35: 1147-1152.
55. Elkind MS, Sciacca RR, Boden-Albala B, et al. Relative elevation in baseline leukocyte count predicts first cerebral infarction. Neurology. 2005;64:2121-2125.
56. Kinlay S, Ganz P. Role of endothelial dysfunction in coronary artery disease and implications for therapy. Am J Cardiol. 1997;80:11I-16I. (Pubitemid 27490822)
57. Hingorani AD, Cross J, Kharbanda RK, et al. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation. 2000;102:994-999.
58. Chan NN, Colhoun HM, Vallance P. Cardiovascular risk factors as determinants of endothelium-dependent and endothelium-independent vascular reactivity in the general population. J Am Coll Cardiol. 2001;38:1814-1820.
59. Charakida M, Donald AE, Terese M, et al. Endothelial dysfunction in childhood infection. Circulation. 2005;111:1660-1665.
60. Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol. 2008;29:1036-1042.
61. Bartynski WS, Boardman JF, Zeigler ZR, et al. Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am J Neuroradiol. 2006;27:2179-2190.
62. Sweany JM, Bartynski WS, Boardman JF. BRecurrent[ posterior reversible encephalopathy syndrome: report of 3 casesVPRES can strike twice! J Comput Assist Tomogr. 2007;31: 148-156.
63. Bartynski WS, Tan HP, Boardman JF, et al. Posterior reversible encephalopathy syndrome after solid organ transplantation. AJNR Am J Neuroradiol. 2008;29:924-930.
64. Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome (PRES). AJNR Am J Neuroradiol. 2007;28:1320-1327.
65. Naidu K, Moodley J, Corr P, et al. Single photon emission and cerebral computerised tomographic scan and transcranial Doppler sonographic findings in eclampsia. Br J Obstet Gynaecol. 1997;104: 1165-1172.
66. Bartynski WS, Boardman JF. Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol. 2008;29:447-455.
67. Kimura S, Kobayashi T, Osaka H, et al. Serial magnetic resonance imaging in post-infectious focal encephalitis due to influenza virus. J Neurol Sci. 1995;131:74-77.
68. Tokunaga Y, Kira R, Takemoto M, et al. Diagnostic usefulness of diffusion-weighted magnetic resonance imaging in influenza-associated acute encephalopathy or encephalitis. Brain Dev. 2000;22:451-453.
69. Bartynski WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol. 2008;29:1043-1049.
70. McKinney AM, Short J, Truwit CL, et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol. 2007;189: 904-912.
71. Horbinski C, Bartynski WS, Carson-Walter E, et al. Reversible encephalopathy after cardiac transplantation: histologic evidence of endothelial activation, T-cell specific trafficking, and vascular endothelial growth factor expression. AJNR Am J Neuroradiol. 2009: Publication preview.
72. Crumpacker CS,Wadhwa S. Cytomegalovirus. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Philadelphia, PA: Elsevier; 2005:1786-1801.
73. Kutza AS, Muhl E, Hackstein H, et al. High incidence of active cytomegalovirus infection among septic patients. Clin Infect Dis. 1998;26:1076-1082. (Pubitemid 128751524)
74. Burns WH. Virus infections complicating bone marrow transplantation. In: Burt RK, Deeg HJ, Lothian ST, Santos GW, eds. On Call in Bone Marrow Transplantation. Georgetown, TX: Landes Bioscience; 1996: 439-451.